Perimeter Medical Imaging AI (TSX-V:PINK, OTC:PYNKF) unveiled its strategic agenda, spotlighting significant events and advancements in its cutting-edge AI technology.
The company will showcase its flagship Perimeter S-Series OCT technology at the upcoming Society of Surgical Oncology (SSO) International Conference on Surgical Cancer Care, scheduled from March 20 to 23, 2024, at the Georgia World Congress Center in Atlanta, Georgia.
In a statement, the company’s CEO Adrian Mendes called the conference “an important opportunity to connect with key customers and educate the broader surgical community about the benefits of using Perimeter's innovative technology to assist with visualizing margins real-time in their ORs."
Looking ahead, a comprehensive corporate update will come during the announcement of Perimeter's fourth quarter/year-end 2023 results on March 28. The event will be accessible via audio webcast and conference call, providing insights into the company's financial performance and strategic outlook.
Mendes also addressed setbacks in securing funding from the federal PSI grant program by the Advanced Research Projects Agency for Health (ARPA-H). Despite falling short in this funding round, the company remains resolute in its commitment to ongoing clinical and product development initiatives.
“Although disappointing, it's important to note that these funds were proposed for future tissue type investigations and related product development. All of our current clinical and product development plans remain on track and within our current financial modeling, including a planned interim read-out from our ongoing clinical trial evaluating the use of proprietary AI combined with our OCT technology during breast conservation surgery,” Mendes told investors.
“We continue to explore other relevant grant funding opportunities and were pleased to receive a term extension of our existing CPRIT grant, ensuring continued access to this funding beyond the interim read-out clinical milestone.”